 |
2018 © Clarivate Analytics
|
 |
 |
 |
 |
| ALLICENSE DEAL OF THE YEAR NOMINEES TO PRESENT AT ALLICENSE 2016. We are thrilled to have representatives from the buyside and sellside of each of the 10 nominated deals (5 M&A and 5 licensing transactions) present during the Allicense 2016 Breakthrough Deal of the Year Nominees rapid-fire presentation scheduled for 2:15 – 3:15 PM. Nominees were announced May 3. Meet the speakers representing the nominees below. |
 |
CLAIRE NAUSSAC, Innate (AstraZeneca/Innate alliance) |
SAMARTH KULKARNI, CRISPR (Vertex/CRISPR alliance) |
| PAUL VAN DER HORST, Galapagos (Gilead/Galapagos alliance) |
BARRY KENNY, Heptares (Pfizer/Heptares alliance) |
 |
 |
 |
 |
 |
| PHIL MCGURK Pfizer (Pfizer/Heptares alliance) |
 |
 |
| DR. MARTIN CROOK, Bristol-Myers Squibb (Bristol-Myers Squibb/Cardioxyl alliance) |
| DR. WILLIAM SHEN, Bristol-Myers Squibb (Bristol-Myers Squibb/Cardioxyl alliance) |
 |
| DR. JEFFREY A. STAFFORD Celgene Quanticel Research (Celgene/Quanticel alliance) |
 |
| MICHAEL ATTAR Celgene (Celgene/Quanticel alliance) |
 |
| ZUBIN BHAGWAGAR Alexion (Alexion/Synageva alliance) |
| MARK BARRETT Genzyme (Sanofi(Genzyme)/Voyager Therapeutics alliance) |
 |
| SHANNON RYAN Gilead (Gilead/Galapagos alliance) |
| JAMES DOUGHERTY Roche (Roche/Foundation Medicine alliance) |
 |